Channakeshava Umeshappa, PhD
Director of Scientific Discoveries
What We Do
Our focus is to pioneer immunotherapeutic treatments that restore balance to the immune system. We are driven by science and innovation, and we strive to develop therapies that:
- Target specific autoimmune disorders and cancers linked to immune dysfunction.
- Preserve the body's natural defenses, avoiding broad immunosuppression and its complications.
- Provide organ-specific immune regulation, offering patients more effective, targeted treatment options.
We are committed to helping people with chronic immune-related diseases live healthier, fuller lives.
Why KYNLiV?
Autoimmune diseases and cancers present some of the most complex challenges in modern medicine, where the immune system mistakenly attacks the body or fails to eliminate harmful cells. While medical advances have been made, there is no cure for many autoimmune diseases, and current treatments often rely on suppressing the immune system broadly — leading to severe side effects such as heightened infection risk.
At KYNLiV, we recognize the urgent need for precision. Our therapies aim to tackle these diseases at their core, without harmful side effects.
Meet Our Team
Cini Mathew John, PhD, RPh
Director of Management and Research
Fazlin Fauzi, MPharm, PhD
Chief Scientist, Data and Informatics
Alice Joshua
Strategic Partnership Advisor
Annette John, MSc
Intern